236 related articles for article (PubMed ID: 3519801)
21. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
Levy L; Shepard CC; Fasal P
Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
[No Abstract] [Full Text] [Related]
22. Characteristics of the multiplication of dapsone-resistant strains of Mycobacterium leprae in mice. Subcommittee on Clinical Trials of the C hemotherapy of Leprosy (THELEP) Scientific Working Group of UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
Lepr Rev; 1988 Mar; 59(1):5-10. PubMed ID: 3294541
[No Abstract] [Full Text] [Related]
23. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
[No Abstract] [Full Text] [Related]
24. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
25. DDS-resistant leprosy.
Neelan PN; Reddy BN
Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):115-8. PubMed ID: 3889186
[No Abstract] [Full Text] [Related]
26. Some characteristics of the action of dapsone on multiplication of Mycobacterium leprae in the mouse.
Levy L; Peters JH
Lepr Rev; 1977 Dec; 48(4):237-45. PubMed ID: 400808
[No Abstract] [Full Text] [Related]
27. [Clinical and paraclinical aspects of secondary drug resistance to 4-4' diaminodiphenylsulfone in a population of leprosy patients in Bamako, Republic of Mali].
Baquillon G; Ferracci C; Diallo J; Saint-Andreé P; Pattyn SR
Acta Leprol; 1981; 85():40-52. PubMed ID: 6805234
[No Abstract] [Full Text] [Related]
28. Primary dapsone resistance in leprosy.
Vaishnavi C; Ganguly NK; Kumar B; Kaur S; Chakravarti RN
Indian J Lepr; 1985; 57(3):507-13. PubMed ID: 3913705
[TBL] [Abstract][Full Text] [Related]
29. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
[No Abstract] [Full Text] [Related]
30. Dormancy, drug resistance or dependency; some thoughts to ponder.
Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
[No Abstract] [Full Text] [Related]
31. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
Shepard CC; Levy L; Fasal P
Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
[No Abstract] [Full Text] [Related]
32. Recent advances in the study of the leprosy bacillus.
Rees RJ
Sci Basis Med Annu Rev; 1969; ():320-35. PubMed ID: 4917843
[No Abstract] [Full Text] [Related]
33. A rapid test for bacillary resistance to dapsone.
Ambrose EJ; Khanolkar SR; Chulawalla RG
Lepr India; 1978 Apr; 50(2):131-43. PubMed ID: 353382
[No Abstract] [Full Text] [Related]
34. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
35. The problem of dapsone-resistant leprosy.
Pearson JM
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605
[No Abstract] [Full Text] [Related]
36. Dapsone-resistant leprosy-the THELEP approach.
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):421-5. PubMed ID: 7042606
[No Abstract] [Full Text] [Related]
37. [Sulfone-resistance of Mycobacterium leprae--monotherapy with diaminodiphenylsulfone--the value of triple-drug combinations].
Floch HA
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):122-5. PubMed ID: 3519797
[TBL] [Abstract][Full Text] [Related]
38. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
Dhople AM
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
[TBL] [Abstract][Full Text] [Related]
39. Does dapsone resistance really matter in the MDT era?
Ji B
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
[No Abstract] [Full Text] [Related]
40. Drug resistance of Mycobacterium leprae, particularly to DDS.
Rees RJ
Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
